Microbot Medical is selling for under 1.51 as of the 21st of March 2025; that is 1.95 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.46. Microbot Medical has more than 62 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microbot Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbot Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Microbot Medical (CY9D) is traded on Stuttgart Exchange in Germany . The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.34 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbot Medical's market, we take the total number of its shares issued and multiply it by Microbot Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Microbot Medical generates negative cash flow from operations
Check Microbot Medical Probability Of Bankruptcy
Microbot Medical Risk Profiles
Although Microbot Medical's alpha and beta are two of the key measurements used to evaluate Microbot Medical's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Microbot Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Idea Optimizer Now
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.